ZEN Graphene Solutions Highlights Results of Annual Shareholder Meeting
Oct 4, 2021
ZEN Graphene Solutions Ltd., a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that shareholders have approved all resolutions put forward at the annual shareholder meeting held on September 27, 2021. These resolutions include several initiatives to better align the company's classifications and communications with its value proposition in nanotechnology and health sciences.
"We are extremely grateful and pleased that our shareholders are as enthusiastic about the new direction of our company as everyone here on the ZEN team. These resolutions will allow us to more properly position ZEN as an IP development company focused on technologies that enhance safety and improve health. We expect these steps to generate additional interest in the U.S. investment community and other markets where our story is currently underserved. These initiatives include potential listings on alternative exchanges in both the U.S. and Canada, a corporate name change, and a long-term incentive program for our employees aligned with these goals," commented Greg Fenton, ZEN CEO.
The Company also recently retained CORE IR, a New York based investor and public relations firm focused on small to mid-cap companies, to assist in establishing relationships in the U.S. capital markets, advise on a potential US listing, interface with investors and engage in PR activities that provide greater visibility for the Company and its mission.
ZEN Graphene Solutions Ltd., a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that shareholders have approved all resolutions put forward at the annual shareholder meeting held on September 27, 2021. These resolutions include several initiatives to better align the company's classifications and communications with its value proposition in nanotechnology and health sciences.